重发-BRIEF-中国药明生物称预计上半年收益将增长16%,净利同比增56%

路透中文
24 Jul
重发-BRIEF-中国<a href="https://laohu8.com/S/02269">药明生物</a>称预计上半年收益将增长16%,净利同比增56%

重发以补上标题前半句百分号

路透7月24日 - WuXi Biologics (Cayman) Inc 2269.HK:

  • 中国药明生物称预计上半年收益将增长约16%;毛利率将同比提升约3.6%;

  • 预计上半年利润及归属于公司权益股东的利润同比分别增长约54%和56%。

浏览详情,请点击此处

(发稿 崔珠珠)

((Zhuzhu.Cui@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10